Healt


 Fisher & Paykel (ASX: FPH) surged by 7% on Friday. Here’s why.

Fisher & Paykel (ASX: FPH) surged by 7% on Friday. Here’s why.

March 22, 2024 04:34 PM AEDT| By Team Kalkine Media

Fisher & Paykel Healthcare Corporation Ltd (,ASX: FPH,) is exceeding expectations in FY 2024, as evidenced by its robust performance on the ASX 200. The company's share price surged by 7.66% to AU$24.17 on 22 March 2022, signaling a strong finish to...

 Jefferies analysts forecast muted earnings in Australian healthcare sector

Jefferies analysts forecast muted earnings in Australian healthcare sector

March 13, 2024 05:14 PM AEDT| By Team Kalkine Media

Jefferies analysts have delivered a cautious outlook for Australian healthcare companies (INDEXASX: XHJ) post the reporting season, anticipating muted earnings in the coming period. The brokerage firm highlights key factors contributing to the subdue...

 Shares of Healius (ASX: HLS) Marks A Week of Remarkable Gains

Shares of Healius (ASX: HLS) Marks A Week of Remarkable Gains

March 08, 2024 04:15 PM AEDT| By Team Kalkine Media

The healthcare landscape is witnessing a significant stir as Shares of Healius Ltd (,ASX: HLS,) showcase an impressive surge of 13% throughout this week. Investors are closely watching the unfolding scenario, anticipating the best weekly gain since D...

 Shares of Healius (ASX: HLS) surges over 14% on commencement of strategic review of assets and structure

Shares of Healius (ASX: HLS) surges over 14% on commencement of strategic review of assets and structure

March 05, 2024 04:58 PM AEDT| By Team Kalkine Media

Shares of medical centre operator Healius (,ASX: HLS,) have witnessed a remarkable surge, advancing by an impressive 14.6% to close at AU$1.29 apiece. In this comprehensive review, we delve into the various factors contributing to this notable upswin...

 Ramsay Health Care (ASX: RHC) Sees Soaring Shares on Impressive Half-year Profits

Ramsay Health Care (ASX: RHC) Sees Soaring Shares on Impressive Half-year Profits

February 29, 2024 05:51 PM AEDT| By Team Kalkine Media

Shares of Ramsay Health Care (,ASX: RHC,) have witnessed a remarkable surge ON 29 February 2024, leaping as much as 7.27% to AU$54.91 apiece. Let's delve into the key factors driving this surge and what it means for investors.,Ramsay Health Care's St...

 Sonic Healthcare (ASX: SHL) releases half-year results, shares in red

Sonic Healthcare (ASX: SHL) releases half-year results, shares in red

February 20, 2024 06:14 PM AEDT| By Team Kalkine Media

In a notable market move, Sonic Healthcare Ltd's (,ASX: SHL,) share price experiences a decline of nearly 7.79%, settling at AU$29.24 on 20 February 2024. This downward trend follows the release of the company's half-year results, outlining both chal...

 Cochlear's stock price drops despite a 29% dividend increase

Cochlear's stock price drops despite a 29% dividend increase

February 19, 2024 06:32 PM AEDT| By Team Kalkine Media

Cochlear Limited (,ASX: COH,) encountered a downturn in its share price on Monday morning, notwithstanding the unveiling of robust earnings for the six months ending 31 December.,The company's shares closed at $334.54 last week. However, the,ASX heal...

 Cochlear Limited (ASX: COH) shares dropped on Monday. Here’s why.

Cochlear Limited (ASX: COH) shares dropped on Monday. Here’s why.

February 19, 2024 05:16 PM AEDT| By Team Kalkine Media

Cochlear Limited's (,ASX: COH,) shares experienced a decline on Monday (19 February 2024), despite the release of its latest earnings report covering the six months to 31 December. Let's delve into the key aspects influencing this market movement.,Ea...

 CSL (ASX: CSL) shares in red, shares CSL 112 phase 3 trial results

CSL (ASX: CSL) shares in red, shares CSL 112 phase 3 trial results

February 12, 2024 04:30 PM AEDT| By Sonal Goyal

Shares of CSL (,ASX: CSL,) faced a downturn on Monday, as the biotechnology firm's announces that the phase 3 trial for its cardiovascular drug, CSL112, failed to meet its primary efficacy endpoint. Let's delve into the details of this impactful even...

 Cochlear (ASX: COH) upgrades FY24 earnings guidance, expects net profit of AU$385-400M

Cochlear (ASX: COH) upgrades FY24 earnings guidance, expects net profit of AU$385-400M

February 08, 2024 01:18 PM AEDT| By Team Kalkine Media

Cochlear Ltd (,ASX: COH,), a leader in hearing solutions, has recently made significant announcements, including the upgrade of FY24 earnings guidance. This article delves into the details of these upgrades and their implications.,Cochlear Ltd has ma...

 Up over 5%, here's why Cochlear's (ASX: COH) shares surging on Tuesday

Up over 5%, here's why Cochlear's (ASX: COH) shares surging on Tuesday

February 06, 2024 05:34 PM AEDT| By Team Kalkine Media

The financial landscape witnessed a tumultuous Tuesday (6 February 2024), with the S&P/ASX 200 Index sliding by 0.58%, causing distress among ASX 200 shares. However, the spotlight remains on Cochlear Limited (,ASX: COH,), an ASX 200 healthcare stock...

 CSL (ASX: CSL) shares up 28% since October end

CSL (ASX: CSL) shares up 28% since October end

February 05, 2024 06:06 PM AEDT| By Team Kalkine Media

The recent fluctuations in CSL Ltd's (,ASX: CSL,) shares have captivated the attention of investors and market enthusiasts alike. Despite a 28% surge since the end of October, the biotech giant finds itself in a challenging position, especially in th...

 ResMed (ASX: RMD) share rice trading in green on Thursday. Here’s why.

ResMed (ASX: RMD) share rice trading in green on Thursday. Here’s why.

January 25, 2024 03:16 PM AEDT| By Team Kalkine Media

Investors in ResMed Inc (,ASX: RMD,) are celebrating as the company's share price experiences a robust surge, climbing 6.5% to AU$28.50 on 25 January 2024. The market excitement follows ResMed's outstanding second-quarter results, surpassing expectat...

 Why are PolyNovo (ASX: PNV) shares trading in green today?

Why are PolyNovo (ASX: PNV) shares trading in green today?

January 22, 2024 02:52 PM AEDT| By Team Kalkine Media

PolyNovo Limited (,ASX: PNV,), a medical device developer, witnessed a notable upswing as its shares rose by 9.78%, reaching AU$1.740 on 22 January 2024. This marks the highest point for PolyNovo's stock since January 5, sparking interest and specula...

 How can GLP-1 drug impact performance of ResMed (ASX: RMD)?

How can GLP-1 drug impact performance of ResMed (ASX: RMD)?

January 18, 2024 07:41 PM AEDT| By Team Kalkine Media

The ResMed Inc. (,ASX: RMD,) share price has navigated a challenging 12 months, experiencing fluctuations driven by market concerns regarding GLP-1 drugs like Ozempic. As the eagerly anticipated Q2 update approaches, investors are contemplating wheth...

 What analysts have to say about CSL (ASX: CSL) shares?

What analysts have to say about CSL (ASX: CSL) shares?

January 18, 2024 07:04 PM AEDT| By Team Kalkine Media

Investors who witnessed the meteoric rise of CSL Limited (,ASX: CSL,) in the early 2020s might find the recent trajectory perplexing. The company, known for its double-digit share price gains, soared from under AU$100 in 2015 to surpass the AU$300 ma...

 A look at ROE and earnings growth of Ansel (ASX: ANN)

A look at ROE and earnings growth of Ansel (ASX: ANN)

January 18, 2024 07:02 PM AEDT| By Team Kalkine Media

In the dynamic realm of financial markets, Ansell's (,ASX: ANN,) stock has surged considerably over the past three months. Investors are often keen to understand the driving forces behind such price movements, especially when it comes to a company's...

 Analysts expects ASX 200 healthcare sector to be affected by cost inflation

Analysts expects ASX 200 healthcare sector to be affected by cost inflation

January 15, 2024 05:28 PM AEDT| By Team Kalkine Media

In the dynamic landscape of the Australian healthcare sector, analysts at Morgan Stanley anticipate ongoing challenges for companies, primarily stemming from cost inflation. As the sub-index for Australian healthcare (INDEXASX: XHJ) experiences a 0.4...

 Morgan Stanley Downgrades Healius (ASX: HLS) Rating. Here’s Why.

Morgan Stanley Downgrades Healius (ASX: HLS) Rating. Here’s Why.

January 12, 2024 04:46 PM AEDT| By Team Kalkine Media

In the fast-paced world of finance, every market move is closely scrutinized. Recently, the spotlight has fallen on Healius (,ASX: HLS,) as Morgan Stanley downgraded the stock from "Equal-weight" to "Underweight," citing uncertainties surrounding the...

 CSL (ASX: CSL) gets limelight in CSL. Here’s why

CSL (ASX: CSL) gets limelight in CSL. Here’s why

January 04, 2024 03:22 PM AEDT| By Team Kalkine Media

The new year brings opportunities for investors to consider new portfolio additions, and CSL Limited (,ASX: CSL,) shares emerge as a highly recommended option.,Overview of Brokers' Positive Ratings on CSL Shares,A substantial number of brokers have i...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.